Prednisolone 5 mg Tablets

DRUG2 trials

Sponsors

Eledon Pharmaceuticals Inc., Oslo University Hospital HF

Conditions

Kidney transplantationProphylaxis of Renal Allograft Rejection

Phase 2

BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Active, not recruitingCTIS2023-503336-41-00

Eledon Pharmaceuticals Inc.Prophylaxis of Renal Allograft Rejection

Start: 2023-11-29Target: 101Updated: 2025-07-22

Phase 4

CALCIGRAN FORTE AND DOSING OF IMMUNOSUPPRESSIVE DRUGS IN KIDNEY TRANSPLANT RECIPIENTS

Not yet recruitingCTIS2024-515164-30-00

Oslo University Hospital HFKidney transplantation

Target: 26Updated: 2024-09-25